This review elucidates gender differences in SpA and raises awareness about the need for gender-related stratification of SpA patients with the concomitant implementation of SpA gender differences in future research and upcoming clinical trials. A deeper knowledge of SpA in women is indispensable to pave the way for real personalized medicine for SpA patients to reduce misdiagnosis and delay in intercepting the disease.
Keyphrases
- clinical trial
- polycystic ovary syndrome
- end stage renal disease
- healthcare
- ejection fraction
- chronic kidney disease
- newly diagnosed
- primary care
- pregnancy outcomes
- prognostic factors
- mental health
- cervical cancer screening
- rheumatoid arthritis
- ankylosing spondylitis
- quality improvement
- breast cancer risk
- insulin resistance